While heart failure (HF) is an uncommon complication of breast cancer, a new study in the Journal of the American College of Cardiology notes individuals treated with trastuzumab-based chemotherapy have a higher risk for HF—but they are not monitored for it, despite recommendations.

Cancer screening rates in the U.S. over the past 15 years remain short of national goals, according to new analysis performed by the Centers for Disease Control and Prevention (CDC).

Jennifer Lim-Dunham, MD, and colleagues at Chicago's Loyola University Medical Center took home the Society for Pediatric Radiology’s Walter E. Berdon Award for best clinical research paper during the group’s annual meeting in Nashville, Tennessee.

CT use has risen over the past 20 years, and new research published in the Journal of the National Cancer Institute finds the modality may increase the risk of brain cancer, especially among children.

Newly engineered liposomes, or 'nano-bubbles,' can deliver chemotherapy drugs on-demand when activated by x-rays. They have proven to be successful in killing bowel cancer cells, according to the Center for Nanoscale BioPhotonics in Adelaide, Australia.

Major healthcare organizations, including branches of the National Institutes of Health (NIH), have launched a $26.5 million study to investigate the genetic and socioeconomic factors surrounding black men’s increased susceptibility to more aggressive forms of prostate cancer, according to an NIH release.

Liver cancer death rates among adults continue to climb across the U.S., according to new research from the Centers for Disease Control and Prevention (CDC).

Multiparametric MRI can be a valuable tool for visualizing prostate changes and monitoring patients after MRI-guided focal laser ablation (FLA), according to a July 10 American Journal of Roentgenology study.